M Ferreri

727 total citations
34 papers, 430 citations indexed

About

M Ferreri is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, M Ferreri has authored 34 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 8 papers in Clinical Psychology. Recurrent topics in M Ferreri's work include Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). M Ferreri is often cited by papers focused on Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). M Ferreri collaborates with scholars based in France and Belgium. M Ferreri's co-authors include Ivan Berlin, Alain Puech, Christine Payan, Francis Lavergne, Élie Hantouche, Françoise Radat, Mohamed Amrani, Marie‐Germaine Bousser, Donald L. Gerard and Philippe Nuss and has published in prestigious journals such as Psychopharmacology, Acta Psychiatrica Scandinavica and Headache The Journal of Head and Face Pain.

In The Last Decade

M Ferreri

33 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ferreri France 10 249 172 128 90 42 34 430
A A Nierenberg United States 10 180 0.7× 159 0.9× 95 0.7× 97 1.1× 37 0.9× 17 379
James T. Hartford United States 11 161 0.6× 196 1.1× 188 1.5× 132 1.5× 25 0.6× 16 463
N. Schooler United States 8 252 1.0× 115 0.7× 71 0.6× 132 1.5× 45 1.1× 18 517
Yiannis G. Papakostas Greece 12 255 1.0× 149 0.9× 59 0.5× 73 0.8× 33 0.8× 28 400
Susan Pelton United States 11 192 0.8× 262 1.5× 87 0.7× 70 0.8× 73 1.7× 16 462
J. Andersen Denmark 10 204 0.8× 119 0.7× 84 0.7× 82 0.9× 37 0.9× 16 370
M.E. Thase United States 11 225 0.9× 223 1.3× 252 2.0× 127 1.4× 49 1.2× 21 593
R T Owen United Kingdom 8 210 0.8× 121 0.7× 178 1.4× 110 1.2× 36 0.9× 9 583
Ahsan Y. Khan United States 10 188 0.8× 154 0.9× 124 1.0× 59 0.7× 85 2.0× 25 467
W. Linford Rees United Kingdom 11 181 0.7× 87 0.5× 94 0.7× 114 1.3× 17 0.4× 24 416

Countries citing papers authored by M Ferreri

Since Specialization
Citations

This map shows the geographic impact of M Ferreri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ferreri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ferreri more than expected).

Fields of papers citing papers by M Ferreri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ferreri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ferreri. The network helps show where M Ferreri may publish in the future.

Co-authorship network of co-authors of M Ferreri

This figure shows the co-authorship network connecting the top 25 collaborators of M Ferreri. A scholar is included among the top collaborators of M Ferreri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ferreri. M Ferreri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallet, Dominique & M Ferreri. (2007). Impacts psychologiques du terrorisme sur les victimes et la population générale. Bulletin de l Académie Nationale de Médecine. 191(6). 1019–1032. 1 indexed citations
2.
Bazin, Nadine, Philippe Nuss, Charles-Siegfried Peretti, et al.. (2007). Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug. European Psychiatry. 23(1). 8–13. 17 indexed citations
3.
Mouchabac, Stéphane, et al.. (2004). [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].. PubMed. 29(5). 438–44. 7 indexed citations
4.
Pontonnier, F, et al.. (2003). [Catatonia de novo, report on a case: immediate vital prognosis and psychiatric prognosis in longer term].. PubMed. 29(1). 72–9. 5 indexed citations
5.
Ferreri, M, Francis Lavergne, Ivan Berlin, Christine Payan, & Alain Puech. (2001). Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. Acta Psychiatrica Scandinavica. 103(1). 66–72. 48 indexed citations
6.
Radat, Françoise, et al.. (1999). Psychiatric Comorbidity Is Related to Headache Induced By Chronic Substance Use in Migraineurs. Headache The Journal of Head and Face Pain. 39(7). 477–480. 75 indexed citations
7.
Jouvent, Roland, et al.. (1999). [Distinction between anxiety state/trait in general practice: a descriptive study].. PubMed. 25(1). 44–9. 9 indexed citations
8.
Ferreri, M, et al.. (1998). Sulpiride in the treatment of pain disorder. European Psychiatry. 13(S4). 319s–319s. 2 indexed citations
9.
Thomas, G., et al.. (1998). Fava's Anger Attacks Questionnaire: evaluation of the French version in depressed patients. European Psychiatry. 13(1). 41–45. 6 indexed citations
10.
Ferreri, M & Élie Hantouche. (1998). Recent clinical trials of hydroxyzine in generalized anxiety disorder. Acta Psychiatrica Scandinavica. 98(s393). 102–108. 37 indexed citations
11.
Ferreri, M. (1997). [Epidemiological approach of inhibition in general practice].. PubMed. 26(24). 1135–40. 1 indexed citations
12.
Berlin, Ivan, et al.. (1996). Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. Psychopharmacology. 127(4). 370–376. 9 indexed citations
13.
Radat, Françoise, Ivan Berlin, O Varoquaux, M Ferreri, & A Puech. (1996). [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].. PubMed. 154(3). 204–6. 1 indexed citations
14.
Ferreri, M, et al.. (1995). A multicentre double‐blind placebo‐controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety. Human Psychopharmacology Clinical and Experimental. 10(3). 181–187. 20 indexed citations
15.
Ferreri, M, et al.. (1995). [Value of hydroxyzine in generalized anxiety disorder: controlled double-blind study versus placebo].. PubMed. 20(6). 785–91. 11 indexed citations
16.
17.
Patris, Michel, S Brion, Grzegorz Burnat, et al.. (1990). A double‐blind multicentre comparison of remoxipride, at two dose levels, and haloperidol. Acta Psychiatrica Scandinavica. 82(S358). 78–82. 24 indexed citations
18.
Ferreri, M. (1989). Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.. PubMed. 4 Suppl 1. 97–101. 11 indexed citations
19.
Ferreri, M, et al.. (1988). [Neurotic inhibition and transnosographic approach. Apropos of a multicenter study of carpipramine].. PubMed. 13(6). 357–65. 2 indexed citations
20.
Ferreri, M, et al.. (1987). [Construction and preliminary validation of an anxiety scale, the FARD (Ferreri anxiety rating diagram)].. PubMed. 87. 704–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026